MLYS logo

Mineralys Therapeutics, Inc. (MLYS) Shareholders Equity

Annual Shareholders Equity:

$191.26M-$49.90M(-20.69%)
December 31, 2024

Summary

  • As of today, MLYS annual stockholders equity is $191.26 million, with the most recent change of -$49.90 million (-20.69%) on December 31, 2024.
  • During the last 3 years, MLYS annual shareholders equity has risen by +$185.19 million (+3050.34%).
  • MLYS annual shareholders equity is now -20.69% below its all-time high of $241.15 million, reached on December 31, 2023.

Performance

MLYS Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

Quarterly Shareholders Equity:

$313.55M-$28.00M(-8.20%)
June 30, 2025

Summary

  • As of today, MLYS quarterly stockholders equity is $313.55 million, with the most recent change of -$28.00 million (-8.20%) on June 30, 2025.
  • Over the past year, MLYS quarterly shareholders equity has increased by +$23.46 million (+8.09%).
  • MLYS quarterly shareholders equity is now -8.20% below its all-time high of $341.56 million, reached on March 31, 2025.

Performance

MLYS Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

MLYS Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-20.7%+8.1%
3Y3 Years+3050.3%-
5Y5 Years+5417.1%+5064.7%

MLYS Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-20.7%+3050.3%-8.2%+822.2%
5Y5-Year-20.7%+5417.1%-8.2%+822.2%
All-TimeAll-Time-20.7%+5417.1%-8.2%+822.2%

MLYS Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$313.55M(-8.2%)
Mar 2025
-
$341.56M(+78.6%)
Dec 2024
$191.26M(-20.7%)
$191.26M(-19.3%)
Sep 2024
-
$236.93M(-18.3%)
Jun 2024
-
$290.10M(-11.6%)
Mar 2024
-
$328.05M(+36.0%)
Dec 2023
$241.15M
$241.15M(-8.7%)
DateAnnualQuarterly
Sep 2023
-
$264.01M(-7.4%)
Jun 2023
-
$285.01M(-3.7%)
Mar 2023
-
$295.88M(+178.1%)
Dec 2022
$106.38M(+1652.2%)
$106.38M(+345.0%)
Sep 2022
-
-$43.41M(-815.1%)
Dec 2021
$6.07M(+268.8%)
-
Dec 2021
-
$6.07M
Dec 2020
-$3.60M
-

FAQ

  • What is Mineralys Therapeutics, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. annual shareholders equity year-on-year change?
  • What is Mineralys Therapeutics, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. quarterly shareholders equity year-on-year change?

What is Mineralys Therapeutics, Inc. annual stockholders equity?

The current annual shareholders equity of MLYS is $191.26M

What is the all-time high annual shareholders equity for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high annual stockholders equity is $241.15M

What is Mineralys Therapeutics, Inc. annual shareholders equity year-on-year change?

Over the past year, MLYS annual stockholders equity has changed by -$49.90M (-20.69%)

What is Mineralys Therapeutics, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of MLYS is $313.55M

What is the all-time high quarterly shareholders equity for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high quarterly stockholders equity is $341.56M

What is Mineralys Therapeutics, Inc. quarterly shareholders equity year-on-year change?

Over the past year, MLYS quarterly stockholders equity has changed by +$23.46M (+8.09%)
On this page